{"id":"W2048348290","doi":"10.3389/fonc.2014.00233","title":"Trials to Overcome Drug Resistance to EGFR and ALK Targeted Therapies – Past, Present, and Future","year":2014,"lang":"en","type":"review","venue":"Frontiers in Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Anaplastic lymphoma kinase; Medicine; Clinical trial; Targeted therapy; Epidermal growth factor receptor; Lung cancer; EGFR inhibitors; Crizotinib; Biomarker; Oncology; Pharmacology; Cancer; Internal medicine; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012783,0.0007404516,0.001333626,0.001871453,0.0002298054,0.0008038156,0.0009132983,0.001185536,0.003455185],"category_scores_gemma":[0.001382824,0.0002228063,0.0007075273,0.001639567,0.0004627431,0.001176417,0.0005123695,0.001528586,0.001498233],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007096613,"about_ca_system_score_gemma":0.001259479,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006741696,"about_ca_topic_score_gemma":0.001933043,"domain_scores_codex":[0.9996929,0.00008877971,0.00004618564,0.00004945497,0.00009837669,0.00002432682],"domain_scores_gemma":[0.9994798,0.0003078209,0.00007117174,0.00001463036,0.00009901555,0.0000276614],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001071203,0.00007595443,0.0001187241,0.02641066,0.0001242062,0.00008966842,0.00003875945,0.0002661949,0.001493921,0.003807653,0.01735454,0.9501126],"study_design_scores_gemma":[0.00007526657,0.0002225201,0.0007974081,0.01028695,0.000210946,0.0009104276,0.00005986901,0.00007761913,0.0006769403,0.002027582,0.9846363,0.0000180953],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001129091,0.9984764,0.00008450192,0.0002638657,0.0001461097,0.00001111809,0.00001508401,0.000004159338,0.0008858584],"genre_scores_gemma":[0.0006949379,0.9980787,0.0002691039,0.0003406263,0.00008441092,0.00001455012,0.00002741932,0.000001361879,0.0004889123],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003455185,"threshold_uncertainty_score":0.01155877,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02839061432387186,"score_gpt":0.4102419312717828,"score_spread":0.381851316947911,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}